Background: cord regeneration. The aim of this study was to investigate the cellular role of miR-133b in neural cells. Methods: PC12 cells and primary cortical neurons (PCNs) were transfected with lenti-miR-133b, lenti-miR-133b inhibitor, plasmid-shRNA-RhoA, plasmid-RhoA and their negative controls. After 48 hours of transfection, the levels of proteins and mRNA or kinase (PD98059), phosphoinositide-3' kinase (PI3K) (LY294002) and ROCK (Y27632) were added into the culture medium. Results: neurite outgrowth. Conversely, inhibition of miR-133b reduced neurite length. We further Conclusions: In summary, our study suggested that miR-133b regulated neurite outgrowth
MiR-133b Promotes Neurite Outgrowth by Targeting RhoA Expression
Xiao Cheng Lu MicroRNAs (miRNAs) are a class of endogenous small non-coding RNAs with a length of 19-23 nucleotides. The mature miRNAs recognizes complementary sites in the 3'UTR of their corresponding target genes, resulting in down-regulation of a wide variety of proteins.
[1] During development, numerous miRNAs have been shown to be involved in neurogenesis and neuronal maturation in the central nervous system (CNS) [2] . Moreover, accumulated studies provided evidence that miRNAs also appeared to play important roles in axon extension and branching, such as miR-9, miR-34a and miR-124 [3] [4] [5] .
MiR-133b is a commonly dys-regulated miRNA in numerous forms of cancer, including lung cancer, gastrointestinal cancer, and prostate cancer [6] [7] [8] . It has been reported that miR-133b was also a key regulator of cardiac hypertrophy by targeting RhoA and Cdc42. [9] In CNS, miR-133b is enriched in the midbrain and plays an important role in differentiation and degeneration of midbrain dopaminergic neurons through repressing Pitx3, a paired-like homeodomain transcription factor [10, 11] . Moreover, recent studies showed that miR-133b was implicated in the functional recovery of spinal cord injury and stroke [12] [13] [14] , while the cellular role of miR-133b in neurite outgrowth of neural cells remained unclear.
PC12 cells, a cell line from the rat pheochromocytoma of the adrenal medulla, have been extensively used as a mature neural cell model of neurite outgrowth with nerve growth factor (NGF) treatment [15] . NGF stimulates neurite outgrowth of PC12 cells by activating numerous intracellular signaling pathways, including mitogen-activated protein kinase (MAPK) pathway, phosphatidylinositol 3-kinase (PI3-K)/Akt, cAMP pathway, and RhoA/ROCK pathway. In this study, we aimed to investigate the role of miR-133b in neurite extension in PC12 cells and primary cortical neurons (PCNs). The results indicated that manipulation of miR-133b expression was associated with neurite outgrowth in PC12 cells. and ERK1/2 pathways, thereby promoting neurite outgrowth. Moreover, we showed that miR-133b was able to reverse the inhibitory effect of chondroitin sulfate proteoglycans (CSPG) on axon regeneration in PCNs.
Materials and Methods

Animals
The laboratory animals used in all experimental procedures were provided by the Department of Animal Experiments, Nanjing Medical University. Animal studies were approved by the Animal Experimental Committee of the Nanjing Medical University and the procedures complied with relevant laws.
PC12
Cell culture PC12 cells (purchased from the Type Culture Collection of the Chinese Academy of Sciences, Shanghai, China) (passage number <10) were cultured at 37 , 5% CO 2 in Roswell Park Memorial Institute (RPMI) 1640 medium (Life Technologies, USA) supplemented with 10% heat-inactivated horse serum, 5% fetal bovine serum (FBS) (Life Technologies, USA), and 100 U/ml penicillin/streptomycin (Beyotime Institute of Biotechnology, China). The medium was changed every 3 days. For neurite outgrowth experiments, PC12 cells were plated at a density 5×10 3 cells/cm 2 on 24-well tissue culture plates coated with ploy-l-lysine.
PCNs culture
PCNs were prepared from embryonic Sprague-Dawley day 18 rats as previously described [16, 17] .
conditions. After removing of the meninges under microscope, the cerebral cortex was collected in Hanks' solution without Ca 2+ and Mg 2+ (D-Hanks) (Life Technologies, USA) and then transferred to trypsin-EDTA (Life Technologies, USA) (0.125% in D-Hanks' solution) incubation for 15 min at 37 °C. After stopping trypsinization with 20% FBS, the cells were mechanical triturating in DMEM/F-12 (HyClone, USA) with 10% FBS, and further centrifuged for 5 minutes at 1000 r/min. Finally, the cells were resuspended in the neurobasal medium (Life Technologies, USA) containing 2% B27 (Life Technologies, USA), 0.5 mM L-glutamine (Life Technologies, USA) and 50U/ml penicillin/streptomycin and plated on poly-L-lysinecoated 24-well or 6-well plates at a density of 2 × 10 5 cells/ml. The medium was replaced with fresh medium every 3 days. A pilot study using immunocytochemistry revealed that over 95% of the cells were positive for the neuronal marker MAP2.
Cell transfection and lentivirus infection
Lentivirus and plasmid transfection of PC12 cells or PCNs were performed as previously reported (shRhoA) or RhoA cDNA contained a neomycin resistance gene for establishing a stable cell line and RFP promoter, respectively. PC12 cells were transfected with plasmids by using Lipofectamine 2000 following the manufacturer's instructions. For lentivirus infections, 2×10 4 PC12 cells or 1×10 5 PCNs were exposed to 1×10 6 virus particles for 12 hours. Twenty four hours after transfection, PC12 cells were differentiated for 48 hours with NGF (100ng/ml, Sigma-Aldrich, USA) In some experiments, the cells were also cultured with LY294002 (10uM, an inhibitor of PI3K) (Sigma-Aldrich, USA), or PD098059 (10uM, an inhibitor of MAP kinase (MAPK) kinase, MEK1) (Sigma-Aldrich, USA).
Measurement of neurite outgrowth
neurite with a length longer than the cell body diameter were measured as positive neurite-bearing cells as previously described. [19, 20] The average neurite length was measured for all neurite-bearing cells in a the longest neurite length, the 5 longest neurites in each experiment were measured and were averaged to yield a single value for each well [21] . Neurite outgrowth was measured on an average of 400 effectively transfected cells per experiment and each experiment was repeated three times.
For neurite inhibition experiments, PCNs were plated in 24-well plates coated with poly-l-lysine or CSPG substrates. Cells were then transfected with lenti-miR-133b/lenti-miR-NC or treated with 50 uM Y27632 (an inhibitor of RhoA/ROCK pathway) (Sigma-Aldrich, USA). CSPG substrates were made as previously described, by incubating 0.5 ug/ml mixed chondroitin sulfate proteoglycan (CSPG) solution (Merck Millipore, Germany) overnight in poly-l-lysine coated plates [22] . For neurite length assessment, the longest neurite per neuron was measured on an average of 400 effectively transfected cells per experiment with a minimum of three experiments per condition.
Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR)
Total RNA was extracted from cultured cells using Trizol Reagent (Life Technologies, USA) following the manufacturer's instructions. RNA samples were quantitated using Biophotometer (Eppendorf, detection) was synthesized with the Prime-Script RT reagent Kit (TaKaRa, China). In addition, quantitative real-time PCR (RT-PCR) was performed using the miScript SYBR Green PCR Kit in 96-well plates according to the manufacturer's protocol using an Applied Biosystem 7500 apparatus. The relative expression levels of miRNA and mRNA were calculated according to the Ct method and normalized by U6 small nucleolar RNA and GAPDH mRNA levels, respectively. Three data points were used and the experiment was replicated in three times.
MTT assay
with lenti-miR-133b or lenti-miR-NC were seeded in 96-well plates at a density of 1×10 5 and incubated washed twice with PBS, formazan products in the cells were dissolved by dimethyl sulfoxide (DMSO, SigmaAldrich, USA) with plate shaking for 10 min. The absorbance was measured at a test wavelength of 570 nm and a reference wavelength of 630 nm. The results were expressed as percentage of the control group. 
Terminal deoxynucleotidyl transferasemediated biotinylated UTP nick end labeling (TUNEL) staining
Apoptosis in PC12 cells transfected with lenti-miR-133b or lenti-miR-NC was detected using the TiterTACS In Situ Detection Kit (R&D systems, USA) according to the manufacturer's instructions. PC12 cells incubated in 100% methanol for 20 minutes at room temperature. After incubation with Proteinase K for 15 min, PC12 cells were treated with peroxide solution for 5 min to quench endogenous peroxidase. Next, cells were labeled with TdT Enzyme for 1 h at 37 and then treated with stop buffer. The cells were incubated with Streptavidin-HRP for 1 h, and absorbance was measured on a microplate reader at a wavelength of 450 nm. In addition, TACS-Nuclease was used to generate positive control, and the negative controls were labeled without TdT Enzyme.
Immunocytochemistry times in PBS. Following permeabilization with 0.1 % TritonX-100 (Sigma-Aldrich, USA) for 10 min, cells were blocked with 5% BSA (Sigma-Aldrich, USA) for 30 min. Cells were then incubated with primary antibody microtubule-associated protein-2 (MAP-2) (1:500, Abcam, UK) or Tuj1 (1:1000, Abcam, UK) overnight at 4 , followed by incubation with the Cy3 (1:500, Abcam, UK) conjugated secondary antibody for 1 h at room
Western blotting
Total protein from cells was extracted with RIPA lysis buffer (Beyotime Institute of Biotechnology, China) supplemented with 1% protease inhibitor (GeneChem, China) and 1% phosphatase inhibitor Millipore, Germany). After blocking with 5% non-fat dry milk for 2h at room temperature, the membranes were incubated with primary antibody, including p-Akt (1:2000, Cell Signaling Technology, USA), total Akt (1:1000, Cell Signaling Technology, USA), p-p38 (1:1000, Cell Signaling Technology, USA), total p38 (1:1000, Cell Signaling Technology, USA), p-ERK1/2 (1:1000, Cell Signaling Technology, USA), total ERK1/2 (1:1000, Cell Signaling Technology, USA), RhoA (1:1000, Cell Signaling Technology, USA), GAPDH (1:2000, Cell overnight. The membranes were then incubated in goat anti-rabbit IgG antibody conjugated to horseradish peroxidase (1:5000, Bioworld Technology Inc, China) at room temperature for 1 h. Finally, bands were measured by experiment and each experiment was replicated at least 3 times.
Statistical Analysis
Data are presented as mean ± SD of three independent experiments. Student's t-test for unpaired
Results
MiR-133b promoted neurite outgrowth in PC12 cells
To investigate whether miR-133b regulates neurite outgrowth, PC12 cells were transfected with lenti-miR-133b or lenti-miR-NC. The overexpression of miR-133b was in neurite extension than those transfected with miR-NC, both in average neurite length (120.81±21.36 um vs 81.88±18.60 um) and longest neurite length (230.91±33.56 um vs 163.20±16.74 um) (Fig. 1B and 1D) . We further examined whether knockdown of miR-133b inhibited the neurite extension. PC12 cells transfected with lenti-miR-133b inhibitor, which 
MiR-133b did not contribute to neural differentiation in PC12 cells
To identify whether miR-133b is involved in NGF-induced neural differentiation, we isolated total RNA from PC12 cells untreated or treated with NGF for 24 or 48 hours. The results of qRT-PCR showed that expression of miR-133b did not alter between two groups. (Fig. 1C) Moreover, in the absence of NGF, overexpression of miR-133b had no effect on neural differentiation in PC12 cells (Fig. 1B and 1D) . Also, we showed that overexpression of miR133b had no effect on cell proliferation and apoptosis by using MTT and TUNEL assay. (Fig.  1E and 1F ) Together, these results suggested that miR-133b mediated neurite outgrowth but not neural differentiation in PC12 cells. was about 95%, which was indicated by positive staining for the neuronal marker MAP-2 (Fig. 6A) . The results showed that overexpression of miR-133b decreased the protein levels of RhoA in PCNs, but had no effect on the expression of RhoA mRNA (Fig. 6B) . Moreover, 3 days after transfection, we observed that miR-133b enriched PCNs extended longer axons than PCNs transfected with miR-NC. (98.70±11.88 um vs 64.87±9.68 um) (Fig. 6C) . RhoA/ROCK pathway has been shown to play an important role in neurite growth inhibition from CSPG after CNS injury. To determine whether suppression of RhoA by miR133b can surmount axon growth restrictions from CSPG via RhoA/ROCK pathway, Y27632, an inhibitor of ROCK (one of the downstream targets of RhoA kinase), was employed. Consistent with previous report, CSPG dramatically inhibited neurite growth of PCNs. However, miR133b reversed the inhibitory effect of CSPG on neurite extension similar to Y27632 (Fig. 6D) .
Discussion
It has been reported that miR-133b was highly expressed in the spinal cord immediately after traumatic injury [13] . Moreover, miR-133b has been shown to implicate in the functional recovery of spinal cord injury and stroke, whereas its cellular role is not fully understood [12, 14] . In this study, we demonstrated that miR-133b regulated neurite outgrowth via MEK/ERK1/2 and PI3K/Akt pathways by RhoA supression. In PC12 cells, overexpression of miR-133b enhanced neurite extension. To further support the role of miR-133b in neurite outgrowth, we investigated the effect of miR-133b inhibition, which showed that blocking studies showed that NGF modulated the expression of a variety of microRNAs, such as miR-21, which acted as an enhancer of NGF signaling [32] . Thus, we further explored whether miR-133b was involved in the neuronal differentiated induced by NGF, whereas the results of real time RT-PCR showed NGF stimulation did not alter the expression of miR-133b in PC12 cells. Additionally, in the absence of NGF, miR-133b alone could not induce neuronal differentiation in PC12 cells. These results suggested miR-133b mediated neurite outgrowth but not neural differentiation in PC12 cells.
as Foxl2, MST2, and RhoA [9, 24, 25]. Among these target genes, RhoA plays an important role in neuronal growth, which negatively regulates axon elongation and branching [33] . In this study, we observed that expression of RhoA was decreased after overexpression of miR133b and increased following miR-133b inhibition, paralleling with the neurites outgrowth. Cellular Physiology and Biochemistry miR-133b induced neurite extension, but had no effect on the axonal length induced by NGF.
growth, whereas PI3K/Akt pathway might be not crucial in the process of neurite outgrowth following NGF stimulation [39] [40] [41] . Our study also indicated that miR-133b did not enhance p38 phosphorylation, another MAPK family member involving in NGF-induced neurite shRNA increased phosphorylation of Akt and ERK1/2 in PC12 cells, which were consistent with previous reports, indicating that down-regulation of RhoA activated ERK1/2 and Akt in leukaemia and HEK 293E cells [30, 31] . Together, these results demonstrated that miR-133b promoted neurite outgrowth via enhancing MEK/ERK and PI3K/Akt pathways by targeting RhoA.
The failure of axon spontaneous regeneration after the CNS injury is partially attributed to the presence of inhibitory molecules in the CNS environment, such as myelin-associated glycoprotein (MAG), Nogo and CSPG [43] [44] [45] . RhoA, acting as an intrinsic modulator of axon lesion models of the CNS and PNS. [46, 48] As described above, upregulation of miR-133b also promoted axon growth in PCNs by suppression of RhoA. We further investigated whether miR-133b could overcome the inhibitory effect of CSPG on axonal regeneration axon outgrowth of PCNs on CSPG substrates. This observation might contribute to, at least and stroke [12, 14] .
In conclusion, our observations suggest that miR-133b mediates neuritic outgrowth by suppression of RhoA, thereby activating MEK/ERK and PI3K/Akt pathways in PC12 cells. Additionally, overexpression of miR-133b can overcome axon growth restrictions from CSPG through inhibition of RhoA/ROCK pathway.
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